av/zealand-pharma-a-s--big.svg

COM:ZEALANDPHARMA

Zealand Pharma A/S

  • Stock

Last Close

697.00

22/11 15:59

Market Cap

65.70B

Beta: -

Volume Today

138.73K

Avg: -

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe NowHelp
Dec '13
Dec '14
Dec '15
Dec '16
Dec '17
Dec '18
Dec '19
Dec '20
Dec '21
Dec '22
Dec '23
average inventory
-3.22M
-
-3.22M
0%
22.85M
-
82.07M
259.16%
59.86M
27.06%
4.61M
92.30%
average payables
11.60M
-
15.93M
37.30%
20.08M
26.05%
20.71M
3.12%
24.58M
18.72%
31.04M
26.26%
45.09M
45.27%
58.42M
29.56%
61.93M
6.01%
122.66M
98.05%
136.18M
11.03%
average receivables
8.80M
-
22.52M
155.97%
104.03M
362.03%
97.75M
6.04%
27.25M
72.12%
19.97M
26.70%
11.81M
40.86%
14.24M
20.56%
61.54M
332.15%
55.19M
10.31%
138.01M
150.04%
book value per share
13.97
-
11.17
20.03%
10.94
2.08%
11.44
4.60%
18.97
65.79%
36.37
91.71%
36.76
1.07%
30.68
16.55%
21.64
29.45%
17.66
18.40%
28.15
59.38%
capex per share
-0.20
-
-0.20
1.58%
-0.18
11.82%
-0.11
38.97%
-0.26
142.56%
-0.13
49.28%
-0.70
428.76%
-0.65
6.18%
-0.52
20.90%
-0.25
50.91%
-0.42
65.58%
capex to depreciation
-0.77
-
-0.76
1.92%
-0.65
14.25%
-0.48
26.07%
-1.52
216.07%
-0.90
41.03%
-1.72
91.88%
-0.59
65.87%
-0.55
6.26%
-0.10
81.95%
-0.84
745.24%
capex to operating cash flow
0.03
-
0.11
295.76%
0.02
83.19%
-0.06
454.65%
0.03
140.78%
0.01
66.17%
0.06
554.83%
0.04
36.69%
0.02
49.78%
0.01
31.94%
0.06
348.92%
capex to revenue
-0.70
-
-0.03
95.79%
-0.02
26.39%
-0.01
48.55%
-0.05
366.82%
-0.11
105.67%
-0.57
435.08%
-0.07
87.54%
-0.08
6.73%
-0.11
48.86%
-0.07
38.48%
cash per share
13.72
-
23.79
73.32%
18.17
23.63%
13.30
26.78%
23.83
79.19%
37.77
58.49%
40.84
8.12%
30.18
26.10%
33.31
10.37%
25.49
23.47%
28.86
13.20%
days of inventory on hand
-2.69K
-
184.18
-
363.84
97.54%
61.00
-
days payables outstanding
5.60K
-
489.82
91.25%
355.31
27.46%
229.02
35.54%
734.24
220.60%
66.12
90.99%
50.60K
76,425.38%
239.02
99.53%
198.32
17.03%
704.25
-
days sales outstanding
559.55
-
82.97
85.17%
336.67
305.78%
34.81
89.66%
83.85
140.91%
75.32
10.17%
139.41
85.09%
13.11
90.59%
137.72
950.10%
147.79
-
debt to assets
0.46
-
0.56
23.29%
0.48
14.94%
0.18
61.51%
0.05
-
0.06
16.14%
0.38
511.58%
0.29
24.38%
0.06
78.26%
debt to equity
1.08
-
1.41
31.43%
1.19
15.59%
0.26
78.49%
0.07
-
0.10
47.53%
0.85
733.55%
0.54
35.96%
0.13
76.87%
dividend yield
0.10
-
earnings yield
-0.14
-
-0.03
74.86%
-0.03
5.71%
-0.06
82.21%
-0.11
85.58%
0.23
306.83%
-0.07
131.48%
-0.10
39.27%
-0.16
63.62%
-0.10
36.60%
-0.03
67.89%
enterprise value
1.05B
-
1.61B
53.69%
3.39B
110.09%
2.60B
23.30%
2.01B
22.44%
1.69B
16.29%
6.96B
312.75%
7.72B
10.94%
5.88B
23.89%
8.68B
47.63%
20.87B
140.46%
enterprise value over ebitda
-5.94
-
-24.10
305.93%
-40.01
65.98%
-21.97
45.09%
-8.18
62.75%
-2.52
69.19%
-12.37
390.81%
-8.86
28.42%
-6.04
31.86%
-13.05
116.16%
-39.16
200.17%
ev to operating cash flow
-6.18
-
-38.22
517.99%
-15.03
60.68%
63.51
522.70%
-7.23
111.38%
-3.66
49.32%
-17.00
364.10%
-11.21
34.04%
-4.85
56.75%
-9.21
89.90%
-49.03
432.27%
ev to sales
159.56
-
10.48
93.43%
18.05
72.14%
11.07
38.68%
14.42
30.27%
44.41
208.10%
168.43
279.24%
21.86
87.02%
20.09
8.08%
83.46
315.37%
60.88
27.05%
free cash flow per share
-7.70
-
-2.06
73.20%
-9.95
382.47%
1.58
115.83%
-10.27
751.58%
-15.13
47.40%
-12.81
15.36%
-18.60
45.23%
-28.79
54.75%
-20.65
28.28%
-7.94
61.54%
free cash flow yield
-0.13
-
-0.02
80.95%
-0.07
164.32%
0.01
122.52%
-0.12
883.23%
-0.18
57.34%
-0.05
70.16%
-0.08
54.97%
-0.20
135.28%
-0.10
48.33%
-0.02
79.24%
graham net net
12.56
-
9.75
22.37%
7.21
26.05%
-3.14
143.55%
17.20
647.99%
34.26
99.19%
30.63
10.60%
11.54
62.31%
10.04
13.05%
9.84
1.98%
2.39
75.74%
graham number
50.52
-
26.87
46.82%
34.88
29.82%
40.38
15.75%
64.60
59.99%
124.50
92.73%
118.26
5.01%
123.42
4.36%
107.54
12.86%
91.13
15.26%
88.75
2.62%
income quality
0.92
-
0.65
29.71%
1.98
204.75%
-0.27
113.44%
1.02
485.22%
-0.79
177.36%
0.72
190.45%
0.81
13.54%
1.19
46.35%
0.78
34.16%
0.60
22.83%
intangibles to total assets
0
-
0
0
0
0
0
0.00
Infinity%
0.02
1,096.06%
0.03
40.29%
0
100%
0.00
Infinity%
interest coverage
-2.29K
-
-36.46
98.41%
-2.49
93.18%
-3.60
44.62%
-13.03
262.24%
43.26
432.09%
-183.45
524.03%
-286.27
56.05%
-256.71
10.33%
-14.46
94.37%
-19.37
33.88%
interest debt per share
0.00
-
12.12
338,402.47%
16.90
39.46%
14.99
11.29%
5.55
62.96%
0.49
91.15%
2.63
435.64%
3.20
21.55%
18.46
477.17%
10.82
41.39%
4.05
62.56%
inventory turnover
-0.14
-
1.98
-
1.00
49.38%
5.98
-
invested capital
1.08
-
1.41
31.43%
1.19
15.59%
0.26
78.49%
0.07
-
0.10
47.53%
0.85
733.55%
0.54
35.96%
0.13
76.87%
market cap
1.34B
-
1.88B
40.68%
3.49B
85.96%
2.59B
25.88%
2.47B
4.68%
2.55B
3.22%
7.96B
212.37%
8.46B
6.37%
6.22B
26.51%
9.30B
49.59%
21.12B
126.97%
net current asset value
293.51M
-
231.51M
21.12%
233.11M
0.69%
-43.26M
118.56%
494.42M
1,242.94%
1.07B
115.46%
1.07B
0.46%
497.51M
53.51%
581.77M
16.94%
592.46M
1.84%
173.75M
70.67%
net debt to ebitda
1.62
-
3.98
145.60%
1.25
68.58%
-0.08
106.03%
1.84
2,540.64%
1.29
30.06%
1.77
37.52%
0.85
51.97%
0.35
58.72%
0.94
168.16%
0.47
50.32%
net income per share
-8.12
-
-2.87
64.63%
-4.94
72.11%
-6.33
28.09%
-9.77
54.39%
18.94
293.76%
-16.91
189.27%
-22.07
30.51%
-23.75
7.62%
-20.90
12.00%
-12.44
40.50%
operating cash flow per share
-7.50
-
-1.86
75.13%
-9.78
424.50%
1.68
117.21%
-10.01
694.75%
-15.00
49.90%
-12.11
19.25%
-17.95
48.18%
-28.27
57.50%
-20.39
27.86%
-7.52
63.12%
payables turnover
0.07
-
0.75
1,043.05%
1.03
37.86%
1.59
55.14%
0.50
68.81%
5.52
1,010.41%
0.01
99.87%
1.53
21,070.12%
1.84
20.52%
0.52
-
receivables turnover
0.65
-
4.40
574.42%
1.08
75.36%
10.49
867.23%
4.35
58.49%
4.85
11.33%
2.62
45.97%
27.83
962.99%
2.65
90.48%
2.47
-
research and ddevelopement to revenue
25.02
-
1.17
95.32%
1.15
2.17%
1.14
0.28%
2.32
103.36%
11.54
396.77%
13.58
17.71%
1.71
87.41%
2.01
17.64%
5.91
193.59%
1.94
67.08%
return on tangible assets
-0.53
-
-0.11
79.44%
-0.18
64.87%
-0.22
23.41%
-0.37
66.68%
0.47
227.99%
-0.36
175.71%
-0.45
25.26%
-0.51
12.79%
-0.63
24.04%
-0.22
64.78%
revenue per share
0.29
-
6.80
2,239.11%
8.14
19.79%
9.66
18.64%
5.02
48.04%
1.24
75.34%
1.22
1.18%
9.21
653.05%
6.82
25.89%
2.25
67.02%
6.06
169.13%
roe
-0.58
-
-0.26
55.78%
-0.45
75.76%
-0.55
22.46%
-0.52
6.88%
0.52
201.07%
-0.46
188.32%
-0.72
56.40%
-1.10
52.55%
-1.18
7.85%
-0.44
62.67%
roic
-0.59
-
-0.13
78.62%
-0.13
1.11%
-0.18
44.06%
-0.36
98.79%
0.54
249.48%
-0.41
175.81%
-0.59
43.16%
-0.56
4.83%
-0.59
4.55%
-0.29
49.92%
sales general and administrative to revenue
5.20
-
0.26
95.02%
0.24
8.23%
0.22
5.91%
0.34
51.87%
2.05
504.77%
1.64
20.04%
0.57
65.05%
0.89
55.44%
2.64
195.64%
0.22
91.84%
shareholders equity per share
13.97
-
11.17
20.03%
10.94
2.08%
11.44
4.60%
18.97
65.79%
36.37
91.71%
36.76
1.07%
30.68
16.55%
21.64
29.45%
17.66
18.40%
28.15
59.38%
stock based compensation to revenue
1.34
-
0.01
99.19%
0.09
729.48%
0.10
7.20%
0.14
48.97%
0.46
218.97%
0.36
22.35%
0.09
75.84%
0.18
111.95%
0.51
176.47%
0.18
64.56%
tangible asset value
316.14M
-
252.83M
20.03%
252.23M
0.24%
278.19M
10.29%
528.47M
89.96%
1.12B
111.23%
1.24B
11.10%
1.14B
7.97%
874.01M
23.43%
815.91M
6.65%
1.58B
93.72%
tangible book value per share
13.97
-
11.17
20.03%
10.94
2.08%
11.44
4.60%
18.97
65.79%
36.37
91.71%
36.69
0.87%
30.68
16.39%
20.39
33.54%
17.66
13.38%
27.93
58.16%
working capital
293.51M
-
498.68M
69.90%
546.06M
9.50%
285.62M
47.69%
627.41M
119.67%
1.07B
69.79%
1.23B
15.64%
667.30M
45.83%
1.39B
107.90%
1.12B
19.20%
1.50B
33.40%

All numbers in (except ratios and percentages)